Free Trial

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.0003 +0.00 (+50.00%)
As of 07/3/2025 12:25 PM Eastern

GCAN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Greater Cannabis vs. Its Competitors

Greater Cannabis (NASDAQ:GCAN) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

In the previous week, Greater Cannabis had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Greater Cannabis and 0 mentions for 180 Life Sciences. Greater Cannabis' average media sentiment score of 0.24 beat 180 Life Sciences' score of 0.00 indicating that Greater Cannabis is being referred to more favorably in the media.

Company Overall Sentiment
Greater Cannabis Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Greater Cannabis beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.13B$5.54B$9.05B
Dividend YieldN/A2.92%5.24%4.02%
P/E RatioN/A4.1827.4320.23
Price / SalesN/A566.62422.11118.64
Price / CashN/A10.3536.8958.07
Price / BookN/A11.778.045.67
Net IncomeN/A$21.15B$3.18B$249.13M
7 Day PerformanceN/A1.54%2.89%3.28%
1 Month PerformanceN/A5.00%3.70%5.56%
1 Year PerformanceN/A2.31%36.15%21.12%

Greater Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.00
+50.0%
N/A-57.1%$0.00N/A0.001News Coverage
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+1.2%
N/A-19.8%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-21.0%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.50
-13.3%
N/A-47.3%$0.00$585.60M0.004
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-1.1%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.02
+41.3%
N/A-97.9%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
-10.6%
N/A-70.4%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:GCAN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners